192
Participants
Start Date
January 31, 2008
Primary Completion Date
July 14, 2009
Study Completion Date
May 20, 2010
Prochymal®
Prochymal® intravenous infusion.
Placebo
Placebo-matching Prochymal® intravenous infusion.
Corticosteroid
Administration will be intravenously as prescribed by the caregiver.
Royal Melbourne Hospital, Parkville
Royal Adelaide Hospital, Adelaide
Royal Perth Hospital, Perth
Memorial Sloan Kettering Cancer Center, New York
Mount Sinai School of Medicine, New York
New York Presbyterian Hospital, New York
Roswell Park Cancer Institute, Buffalo
Western Pennsylvania Hospital, Pittsburgh
Oncology Hematology Association, Pittsburgh
University of Pittsburgh Cancer Centers, Pittsburgh
Penn State Milton S. Hershey Medical Center, Hershey
Abramson Cancer Center, University of Pennsylvania Health System, Philadelphia
Thomas Jefferson University, Philadelphia
Virginia Commonwealth University, Richmond
Wake Forest University School of Medicine, Winston-Salem
University of North Carolina Hospitals, Chapel Hill
Duke University Health System, Durham
Medical University of South Carolina(MUSC), Charleston
Emory University, Atlanta
Northside Hospital, Atlanta
University of Florida, Gainesville
University of Alabama Birmingham (UAB) Hospital, Birmingham
University of Mississippi Medical Center, Jackson
University of Louisville, Louisville
Ohio State University, Columbus
Jewish Hospital, Cincinnati
Indiana University Cancer Center, Indianapolis
St. Francis Cancer Center, Indianapolis
Barbara Ann Karmanos Cancer Institute, Detroit
Medical College of Wisconsin, Milwaukee
Mayo Medical Center, Rochester
Loyola University Medical Center, Maywood
Northwestern Center for Clinical Research, Chicago
Rush University Medical Center, Chicago
University of Chicago Hospitals, Chicago
Washington University School of Medicine, St Louis
Kansas City Cancer Center, Lee's Summit
Baylor University Medical Center, Dallas
MD Anderson Cancer Center, Houston
Texas Transplant Institute, San Antonio
Rocky Mountain Cancer Center, Denver
UCLA Medical Center, Los Angeles
University of California Medical Center, San Francisco
Fred Hutchinson Cancer Research Center, Seattle
Tufts New England Medical Center, Boston
Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston
Beth Israel Deaconess Medical Center, Boston
St. Vincent's Hospital, Darlinghurst
Royal Brisbane Hospital, Herston
Peter Lougheed Centre, Calgary
Ottawa Hospital, Ottawa
Princess Margaret Hospital, Toronto
Lead Sponsor
Mesoblast, Inc.
INDUSTRY